FDA Drug Application (022083) for EXELON by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number022083
Product Number001
FormFILM, EXTENDED RELEASE;TRANSDERMAL
Dosage4.6MG/24HR
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEXELON
Active IngredientRIVASTIGMINE

Active IngredientCount
List of drugs with Active Ingredient RIVASTIGMINE2
List of drugs with Active Ingredient RIVASTIGMINE TARTRATE3


Back to FDA Applications sponsored by NOVARTIS